DAMAGING CARDIAC GENE VARIANTS DETERMINE RESPONSE TO LVAD THERAPY
Only 1 of the 10 patients with damaging cardiac gene variants improved their ejection fraction to greater than 45% post LVAD. 4 of the 5 patients without mutations improved their ejection fraction to greater than 45%, p-value=.03 Conclusion: Damaging cardiac gene variants are common in this populati...
Gespeichert in:
| Veröffentlicht in: | Journal of the American College of Cardiology 2015-03, Vol.65 (10), p.A891-A891 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | A891 |
|---|---|
| container_issue | 10 |
| container_start_page | A891 |
| container_title | Journal of the American College of Cardiology |
| container_volume | 65 |
| creator | Rome, Eric Dhar, Kajari Moulton, Alexandra Zhao, Junhan Kittrell, Jeff Eudy, James Raichlin, Eugenia Um, John Moulton, Michael Thiele, Geoffrey Redder, Ronald Anderson, Daniel Lowes, Brian |
| description | Only 1 of the 10 patients with damaging cardiac gene variants improved their ejection fraction to greater than 45% post LVAD. 4 of the 5 patients without mutations improved their ejection fraction to greater than 45%, p-value=.03 Conclusion: Damaging cardiac gene variants are common in this population. |
| doi_str_mv | 10.1016/S0735-1097(15)60891-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1675989982</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109715608919</els_id><sourcerecordid>3666765661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1302-6b318777a9cd281d19423fb52290ddc226893e543d4170b1dd3ffae76495f69e3</originalsourceid><addsrcrecordid>eNqFkNFKwzAUhoMoOKePIBS80YtqTtMkzZWEtnaFrRttHXgVuiaFDl1nugm-vd0m3np14PD9_-F8CN0CfgQM7KnAnFAXsOD3QB8YDgS44gyNgNLAJVTwczT6Qy7RVd-vMcYsADFCMpIzmaRZ4oQyj1IZOkmcxc5S5qnMysKJ4jLOZ-mwyuNiMc-K2CnnznQpI6ecxLlcvF2ji6Z6783N7xyj15e4DCfudJ6koZy6NRDsuWxFIOCcV6LWXgAahO-RZkU9T2Cta89jgSCG-kT7wPEKtCZNUxnOfEEbJgwZo7tT79Z2n3vT79S629vNcFIB41QEQgTeQNETVduu761p1Na2H5X9VoDVwZY62lIHFQqoOtpSYsg9n3JmeOGrNVb1dWs2tdGtNfVO6a79p-EHG5hpUg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1675989982</pqid></control><display><type>article</type><title>DAMAGING CARDIAC GENE VARIANTS DETERMINE RESPONSE TO LVAD THERAPY</title><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Rome, Eric ; Dhar, Kajari ; Moulton, Alexandra ; Zhao, Junhan ; Kittrell, Jeff ; Eudy, James ; Raichlin, Eugenia ; Um, John ; Moulton, Michael ; Thiele, Geoffrey ; Redder, Ronald ; Anderson, Daniel ; Lowes, Brian</creator><creatorcontrib>Rome, Eric ; Dhar, Kajari ; Moulton, Alexandra ; Zhao, Junhan ; Kittrell, Jeff ; Eudy, James ; Raichlin, Eugenia ; Um, John ; Moulton, Michael ; Thiele, Geoffrey ; Redder, Ronald ; Anderson, Daniel ; Lowes, Brian</creatorcontrib><description>Only 1 of the 10 patients with damaging cardiac gene variants improved their ejection fraction to greater than 45% post LVAD. 4 of the 5 patients without mutations improved their ejection fraction to greater than 45%, p-value=.03 Conclusion: Damaging cardiac gene variants are common in this population.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/S0735-1097(15)60891-9</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Cardiology ; Cardiomyopathy ; Deoxyribonucleic acid ; DNA ; Genes</subject><ispartof>Journal of the American College of Cardiology, 2015-03, Vol.65 (10), p.A891-A891</ispartof><rights>2015 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Mar 17, 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0735-1097(15)60891-9$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids></links><search><creatorcontrib>Rome, Eric</creatorcontrib><creatorcontrib>Dhar, Kajari</creatorcontrib><creatorcontrib>Moulton, Alexandra</creatorcontrib><creatorcontrib>Zhao, Junhan</creatorcontrib><creatorcontrib>Kittrell, Jeff</creatorcontrib><creatorcontrib>Eudy, James</creatorcontrib><creatorcontrib>Raichlin, Eugenia</creatorcontrib><creatorcontrib>Um, John</creatorcontrib><creatorcontrib>Moulton, Michael</creatorcontrib><creatorcontrib>Thiele, Geoffrey</creatorcontrib><creatorcontrib>Redder, Ronald</creatorcontrib><creatorcontrib>Anderson, Daniel</creatorcontrib><creatorcontrib>Lowes, Brian</creatorcontrib><title>DAMAGING CARDIAC GENE VARIANTS DETERMINE RESPONSE TO LVAD THERAPY</title><title>Journal of the American College of Cardiology</title><description>Only 1 of the 10 patients with damaging cardiac gene variants improved their ejection fraction to greater than 45% post LVAD. 4 of the 5 patients without mutations improved their ejection fraction to greater than 45%, p-value=.03 Conclusion: Damaging cardiac gene variants are common in this population.</description><subject>Cardiology</subject><subject>Cardiomyopathy</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Genes</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqFkNFKwzAUhoMoOKePIBS80YtqTtMkzZWEtnaFrRttHXgVuiaFDl1nugm-vd0m3np14PD9_-F8CN0CfgQM7KnAnFAXsOD3QB8YDgS44gyNgNLAJVTwczT6Qy7RVd-vMcYsADFCMpIzmaRZ4oQyj1IZOkmcxc5S5qnMysKJ4jLOZ-mwyuNiMc-K2CnnznQpI6ecxLlcvF2ji6Z6783N7xyj15e4DCfudJ6koZy6NRDsuWxFIOCcV6LWXgAahO-RZkU9T2Cta89jgSCG-kT7wPEKtCZNUxnOfEEbJgwZo7tT79Z2n3vT79S629vNcFIB41QEQgTeQNETVduu761p1Na2H5X9VoDVwZY62lIHFQqoOtpSYsg9n3JmeOGrNVb1dWs2tdGtNfVO6a79p-EHG5hpUg</recordid><startdate>20150317</startdate><enddate>20150317</enddate><creator>Rome, Eric</creator><creator>Dhar, Kajari</creator><creator>Moulton, Alexandra</creator><creator>Zhao, Junhan</creator><creator>Kittrell, Jeff</creator><creator>Eudy, James</creator><creator>Raichlin, Eugenia</creator><creator>Um, John</creator><creator>Moulton, Michael</creator><creator>Thiele, Geoffrey</creator><creator>Redder, Ronald</creator><creator>Anderson, Daniel</creator><creator>Lowes, Brian</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20150317</creationdate><title>DAMAGING CARDIAC GENE VARIANTS DETERMINE RESPONSE TO LVAD THERAPY</title><author>Rome, Eric ; Dhar, Kajari ; Moulton, Alexandra ; Zhao, Junhan ; Kittrell, Jeff ; Eudy, James ; Raichlin, Eugenia ; Um, John ; Moulton, Michael ; Thiele, Geoffrey ; Redder, Ronald ; Anderson, Daniel ; Lowes, Brian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1302-6b318777a9cd281d19423fb52290ddc226893e543d4170b1dd3ffae76495f69e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Cardiology</topic><topic>Cardiomyopathy</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Genes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rome, Eric</creatorcontrib><creatorcontrib>Dhar, Kajari</creatorcontrib><creatorcontrib>Moulton, Alexandra</creatorcontrib><creatorcontrib>Zhao, Junhan</creatorcontrib><creatorcontrib>Kittrell, Jeff</creatorcontrib><creatorcontrib>Eudy, James</creatorcontrib><creatorcontrib>Raichlin, Eugenia</creatorcontrib><creatorcontrib>Um, John</creatorcontrib><creatorcontrib>Moulton, Michael</creatorcontrib><creatorcontrib>Thiele, Geoffrey</creatorcontrib><creatorcontrib>Redder, Ronald</creatorcontrib><creatorcontrib>Anderson, Daniel</creatorcontrib><creatorcontrib>Lowes, Brian</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rome, Eric</au><au>Dhar, Kajari</au><au>Moulton, Alexandra</au><au>Zhao, Junhan</au><au>Kittrell, Jeff</au><au>Eudy, James</au><au>Raichlin, Eugenia</au><au>Um, John</au><au>Moulton, Michael</au><au>Thiele, Geoffrey</au><au>Redder, Ronald</au><au>Anderson, Daniel</au><au>Lowes, Brian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DAMAGING CARDIAC GENE VARIANTS DETERMINE RESPONSE TO LVAD THERAPY</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2015-03-17</date><risdate>2015</risdate><volume>65</volume><issue>10</issue><spage>A891</spage><epage>A891</epage><pages>A891-A891</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Only 1 of the 10 patients with damaging cardiac gene variants improved their ejection fraction to greater than 45% post LVAD. 4 of the 5 patients without mutations improved their ejection fraction to greater than 45%, p-value=.03 Conclusion: Damaging cardiac gene variants are common in this population.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/S0735-1097(15)60891-9</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0735-1097 |
| ispartof | Journal of the American College of Cardiology, 2015-03, Vol.65 (10), p.A891-A891 |
| issn | 0735-1097 1558-3597 |
| language | eng |
| recordid | cdi_proquest_journals_1675989982 |
| source | Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Cardiology Cardiomyopathy Deoxyribonucleic acid DNA Genes |
| title | DAMAGING CARDIAC GENE VARIANTS DETERMINE RESPONSE TO LVAD THERAPY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T19%3A32%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DAMAGING%20CARDIAC%20GENE%20VARIANTS%20DETERMINE%20RESPONSE%20TO%20LVAD%20THERAPY&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Rome,%20Eric&rft.date=2015-03-17&rft.volume=65&rft.issue=10&rft.spage=A891&rft.epage=A891&rft.pages=A891-A891&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/S0735-1097(15)60891-9&rft_dat=%3Cproquest_cross%3E3666765661%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1675989982&rft_id=info:pmid/&rft_els_id=S0735109715608919&rfr_iscdi=true |